OMGA   $0.1426  -10.82% Market Open

Omega Therapeutics, Inc.
Total Cash 45.85M
totalCashPerShare 0.831
EBITDA -78.89M
Total Debt 126.95M
quickRatio 1.825
currentRatio 2.195
Total Revenue 6.31M
debtToEquity 483.394
Revenue/Share 0.114
ROA -0.25373
ROE -1.2914599
grossProfits
freeCashflow -41.81M
operatingCashflow -64.60M
earningsGrowth
revenueGrowth 1.812
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -7.76945
profitMargins 0.0
enterpriseValue 143.42M
forwardPE -1.2417582
floatShares 21.33M
sharesOutstanding 55.16M
sharesShort 6.03M
sharesShortPriorMonth 5.62M
dateShortInterest
sharesPercentSharesOut 0.11%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.94%
Short Ratio help_outline 31.09%
shortPercentOfFloat 0.31%
impliedSharesOutstanding
bookValue 0.476
Price To Book help_outline 2.37
earningsQuarterlyGrowth
netIncomeToCommon -78.90M
trailingEps -1.37%
forwardEps -0.91%
enterpriseToEbitda -1.82
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.28 3Q 2024
institutionsCount 83
lastUpdated Nov. 7, 2024, 5:13 a.m.